{
    "2019-03-08": [
        [
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)所属企业Frontage向联交所递交更新后上市申请文件",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "Frontage",
                        "联交所",
                        "上市申请"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2018年报前瞻:行业增速预期有望提升、加大配置中小市值标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业增速",
                        "中小市值标的",
                        "2018年报"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}